BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23698598)

  • 1. Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Laskin BL; Maisel J; Goebel J; Yin HJ; Luo G; Khoury JC; Davies SM; Jodele S
    Transplantation; 2013 Jul; 96(2):217-23. PubMed ID: 23698598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.
    Sakamoto K; Imamura T; Osone S; Nishimura A; Nishida M; Ishida H; Hosoi H
    Pediatr Transplant; 2015 Jun; 19(4):E97-100. PubMed ID: 25735190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Masuda Y; Fujino T; Kaneko T; Utsumi K; Arai T; Ishikawa A; Wakamatsu K; Tajika K; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Jan; 61(1):34-41. PubMed ID: 21166941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.
    Chua JS; Baelde HJ; Zandbergen M; Wilhelmus S; van Es LA; de Fijter JW; Bruijn JA; Bajema IM; Cohen D
    J Am Soc Nephrol; 2015 Sep; 26(9):2239-47. PubMed ID: 25573909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM; Kremer J; Ali FN; Curley J; Marino S; Chang A; Kadambi PV
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
    Sartain S; Shubert S; Wu MF; Wang T; Martinez C
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.
    Brinkerhoff BT; Houghton DC; Troxell ML
    Mod Pathol; 2016 Jun; 29(6):637-52. PubMed ID: 27015134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Transplantation-Associated Thrombotic Microangiopathy (TA-TMA) and Comparison between Renal TA-TMA and Intestinal TA-TMA: Autopsy Study.
    Yamada R; Nemoto T; Ohashi K; Tonooka A; Horiguchi SI; Motoi T; Hishima T
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):178-188. PubMed ID: 31491486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney.
    Batal I; Girnita A; Zeevi A; Saab BA; Stockhausen S; Shapiro R; Basu A; Tan H; Morgan C; Randhawa P
    Mod Pathol; 2008 Dec; 21(12):1490-8. PubMed ID: 18820671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kidney injury in transplantation-associated thrombotic microangiopathy].
    Lu M; Zou WZ; Zhang Y; Wang SL; Wang W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):392-4. PubMed ID: 18677386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.
    Ding Y; Yu X; Wu L; Tan Y; Qu Z; Yu F
    Front Immunol; 2021; 12():654652. PubMed ID: 34276649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
    Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
    Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy.
    Batal I; Zainah H; Stockhausen S; Basu A; Tan H; Shapiro R; Zeevi A; Girnita A; Randhawa P
    Mod Pathol; 2009 Nov; 22(11):1468-76. PubMed ID: 19734851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
    El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
    Benítez Carabante MI; Bueno D; Alonso García L; López Torija I; Marsal J; Fernandez Navarro JM; Uria Oficialdegui ML; Panesso M; Molina B; Beléndez Bieler C; Palomo P; Pérez Martínez A; Diaz-de-Heredia C
    Transplant Cell Ther; 2024 Jun; 30(6):601.e1-601.e13. PubMed ID: 38521410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.